KR19990077157A - 유방암의 치료 또는 예방을 위한 약학적 조성물의 제조를 위한센트크로만의 l－거울상이성질체의 사용 - Google Patents

유방암의 치료 또는 예방을 위한 약학적 조성물의 제조를 위한센트크로만의 l－거울상이성질체의 사용 Download PDF

Info

Publication number
KR19990077157A
KR19990077157A KR1019980705295A KR19980705295A KR19990077157A KR 19990077157 A KR19990077157 A KR 19990077157A KR 1019980705295 A KR1019980705295 A KR 1019980705295A KR 19980705295 A KR19980705295 A KR 19980705295A KR 19990077157 A KR19990077157 A KR 19990077157A
Authority
KR
South Korea
Prior art keywords
breast cancer
treatment
pharmaceutically acceptable
phenyl
enantiomer
Prior art date
Application number
KR1019980705295A
Other languages
English (en)
Korean (ko)
Inventor
미카엘 샬미
베드 프라카쉬 캄보이
옴카르 프라사드 아스타나
수프라브하트 레이
Original Assignee
한센 핀 베네드, 안네 제헤르
노보 노르디스크 에이/에스
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 한센 핀 베네드, 안네 제헤르, 노보 노르디스크 에이/에스 filed Critical 한센 핀 베네드, 안네 제헤르
Publication of KR19990077157A publication Critical patent/KR19990077157A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
KR1019980705295A 1996-01-11 1997-01-09 유방암의 치료 또는 예방을 위한 약학적 조성물의 제조를 위한센트크로만의 l－거울상이성질체의 사용 KR19990077157A (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US1000096P 1996-01-11 1996-01-11
US60/010,000 1996-01-11
DK776/96 1996-07-11
DK77696 1996-07-11

Publications (1)

Publication Number Publication Date
KR19990077157A true KR19990077157A (ko) 1999-10-25

Family

ID=26064631

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019980705295A KR19990077157A (ko) 1996-01-11 1997-01-09 유방암의 치료 또는 예방을 위한 약학적 조성물의 제조를 위한센트크로만의 l－거울상이성질체의 사용

Country Status (12)

Country Link
EP (1) EP0873119A1 (no)
JP (1) JP2001500101A (no)
KR (1) KR19990077157A (no)
AU (1) AU1367197A (no)
BR (1) BR9706966A (no)
CA (1) CA2241462A1 (no)
CZ (1) CZ217198A3 (no)
HU (1) HUP9901633A3 (no)
IL (1) IL124881A0 (no)
NO (1) NO983177L (no)
PL (1) PL328135A1 (no)
WO (1) WO1997025034A1 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1028724A1 (en) * 1997-11-10 2000-08-23 Novo Nordisk A/S Transdermal delivery of 3,4-diarylchromans
US6465445B1 (en) 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
AU2004200099B2 (en) * 1998-06-11 2006-11-02 Endorecherche, Inc. Medical Uses of A Selective Estrogen Receptor Modulator in Combination with Sex Steroid Precursors
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
AU2011253842B2 (en) * 1998-06-11 2014-08-14 Endorecherche Inc. Medical Uses of a Selective Estrogen Receptor Modulator in Combination with Sex Steroid Precursors
CN106038572A (zh) 2004-10-20 2016-10-26 恩多研究公司 性甾体前体单独或与选择性雌激素受体调节剂联合用于预防和治疗绝经后女性的性功能障碍
US8268806B2 (en) 2007-08-10 2012-09-18 Endorecherche, Inc. Pharmaceutical compositions
CA2702710C (en) 2007-10-16 2013-05-07 Repros Therapeutics, Inc. Trans-clomiphene for metabolic syndrome
US20100317635A1 (en) 2009-06-16 2010-12-16 Endorecherche, Inc. Treatment of hot flushes, vasomotor symptoms, and night sweats with sex steroid precursors in combination with selective estrogen receptor modulators
WO2011156908A1 (en) 2010-06-16 2011-12-22 Endorecherche, Inc. Methods of treating or preventing estrogen-related diseases
ES2681023T3 (es) 2012-02-29 2018-09-11 Repros Therapeutics Inc. Terapia de combinación para tratar el déficit de andrógenos
US9744177B2 (en) 2014-03-10 2017-08-29 Endorecherche, Inc. Treatment of male androgen deficiency symptoms or diseases with sex steroid precursor combined with SERM
CN108348605B (zh) 2015-11-10 2023-06-09 帕拉卡林治疗公司 用pdgf-cc抑制剂和抗雌激素治疗er阴性乳癌

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4447622A (en) * 1981-09-22 1984-05-08 Council Of Scientific And Industrial Research Rafi Marg Preparation of l- and d-isomers of dl-3,4-trans-2,2-disubstituted-3,4-diarylchromans and derivatives thereof

Also Published As

Publication number Publication date
NO983177L (no) 1998-07-10
AU1367197A (en) 1997-08-01
CA2241462A1 (en) 1997-07-17
BR9706966A (pt) 1999-05-04
HUP9901633A2 (hu) 1999-10-28
WO1997025034A1 (en) 1997-07-17
CZ217198A3 (cs) 1998-11-11
PL328135A1 (en) 1999-01-18
JP2001500101A (ja) 2001-01-09
IL124881A0 (en) 1999-01-26
EP0873119A1 (en) 1998-10-28
HUP9901633A3 (en) 2000-02-28

Similar Documents

Publication Publication Date Title
AU2009200258B2 (en) Methods of treating and/or suppressing weight gain
RU2166940C2 (ru) Способ уменьшения потерь костной ткани, способ лечения остеопороза и применение соединения
KR101731008B1 (ko) 에스트로겐-관련 질병의 치료 또는 예방 방법
KR19990077157A (ko) 유방암의 치료 또는 예방을 위한 약학적 조성물의 제조를 위한센트크로만의 l－거울상이성질체의 사용
EP0873122B1 (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of prostatic carcinoma
JP2000506508A (ja) 良性前立腺肥大の治療又は予防のための医薬組成物の製造のための３，４―ジフェニルクロマンの使用
KR19990077156A (ko) 폐경기 증상의 치료 또는 예방을 위한 약학적 조성물의제조를 위한 3,4-디페닐크로만의 사용
CZ212397A3 (en) Use of 3,4-diphenylchromans for preparing pharmaceutical preparations for treating or prophylaxis of hyperlipoproteinaemia, hypertriacylglycerolaemia, hyperlipidaemia, hypercholesterolaemia, arteriosclerosis and reduction of blood sedimentation
KR19980701547A (ko) 비만의 치료 또는 예방용 약학적 조성물의 제조를 위한 3,4-디페닐크로만의 사용(use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of obesity)
US5886021A (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for vasodilatory treatment or prophylaxis
CN1207038A (zh) 3,4－二苯基苯并二氢吡喃在生产预防或治疗绝经症状的药物组合物中的应用
WO1999048497A1 (en) USE OF 3,4-DIPHENYLCHROMANS FOR THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION FOR LOWERING PLASMA LEVELS OF Lp(a) IN A HUMAN OR SUB-HUMAN PRIMATE
CN1207037A (zh) 西替考马l－对映体在制备治疗或预防乳癌药物组合物中的应用
MXPA97005379A (en) Use of the 3,4-difenil-chromians for the manufacture of a pharmaceutical composition for treatment or profilaxis vasodilatad
MXPA97005214A (en) Use of the 3,4-difenil-chromanos for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of hyperlipoproteinemia, hypertriglyceridemia, hyperlipidemia or hypercholesterolemia or arterioesclerosis or for anti-treatment
KR19980701382A (ko) 고리포단백혈증, 고트리글리세리드혈증, 고지방혈증 또는 고콜레스테롤혈증, 또는 동맥경화증의 치료 또는 예방용 또는 항응고제 치료용 약학적 조성물의 제조를 위한 3,4-디페닐크로만의 사용

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid